MEB Begins Implementation of ilumen In the United Kingdom
Filed with ASX · · 1 page · English
Earlier from TrivarX
- Underwritten Share Purchase Plan Update
- MEB to Raise up to $3.5m By Way of a Placement and SPP
- Medibio Granted CE Mark Approval for MEBsleep
- Consumer Mental Health App Initial testing phase commenced
- US FDA advises further data needed for MEBsleep approval
Later from TrivarX
- Supplementary Prospectus
- MEB Share Purchase Plan Closes Strongly Oversubscribed
- Consumer Mental Health App Development - Second Test Phase
- Re-submission of FDA 510(k) application
- Medibio strengthens its IP protection
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX